# Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

> **NCT07336992** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 580 (estimated)

## Conditions studied

- Spontaneous Intracerebral Hemorrhage

## Interventions

- **DRUG:** Treatment administration (Levetiracetam or placebo)
- **RADIATION:** Neuroimaging
- **DIAGNOSTIC_TEST:** National Institute of Health Stroke Scale (NIHSS)
- **BEHAVIORAL:** Modified Rankin Scale (mRS)
- **BEHAVIORAL:** Euroqol test (EQ-5D-5L)
- **BEHAVIORAL:** Montreal Cognitive Assessment (MoCA)
- **BEHAVIORAL:** Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog)
- **BEHAVIORAL:** Hospital Anxiety and Depression Scale (HADS)

## Key facts

- **NCT ID:** NCT07336992
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-02
- **Primary completion:** 2029-07-02
- **Final completion:** 2030-01-02
- **Target enrollment:** 580 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07336992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07336992, "Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07336992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*